Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 224 articles:
HTML format
Text format



Single Articles


    August 2018
  1. SHIMA K, Ledig S, Loeper N, Schiefer A, et al
    Effective inhibition of rifampin-resistant Chlamydia trachomatis by the novel DNA-dependent RNA-polymerase inhibitor Corallopyronin A.
    Int J Antimicrob Agents. 2018 Aug 6. pii: S0924-8579(18)30224.
    PubMed     Text format    


  2. CARMEN L, Andrea DC, Eleonora M, Ilaria P, et al
    Assessing antibiotic resistance gene load in vegan, vegetarian and omnivore human gut microbiota.
    Int J Antimicrob Agents. 2018 Aug 3. pii: S0924-8579(18)30222.
    PubMed     Text format     Abstract available


  3. KLIBI A, Maaroufi A, Torres C, Jouini A, et al
    Detection and characterization of methicillin resistant and susceptible coagulase-negative Staphylococci in milk from cows with clinical mastitis in Tunisia.
    Int J Antimicrob Agents. 2018 Aug 2. pii: S0924-8579(18)30225.
    PubMed     Text format     Abstract available


    July 2018
  4. YAN Q, Karau MJ, Raval YS, Patel R, et al
    in vitro Activity of Oritavancin in Combination with Rifampin or Gentamicin Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus epidermidis Biofilms.
    Int J Antimicrob Agents. 2018 Jul 23. pii: S0924-8579(18)30203.
    PubMed     Text format     Abstract available


  5. SANTONA A, Taviani E, Hoang HM, Fiamma M, et al
    Emergence of unusual vanA/vanB2 genotype in a highly mutated vanB2-Vancomycin Resistant Hospital Associated E. faecium background, in Vietnam.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30197.
    PubMed     Text format     Abstract available


  6. SEIFERT H, Blondeau J, Dowzicky MJ
    In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance - a report from the T.E.S.T. study.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30194.
    PubMed     Text format     Abstract available


    June 2018
  7. LIN YT, Cheng YH, Juan CH, Wu PF, et al
    High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.
    Int J Antimicrob Agents. 2018 Jun 12. pii: S0924-8579(18)30165.
    PubMed     Text format     Abstract available


  8. MITGANG EA, Hartley DM, Malchione MD, Koch M, et al
    Review and Mapping of Carbapenem-resistant Enterobacteriaceae in Africa: Using Diverse Data to Inform Surveillance Gaps.
    Int J Antimicrob Agents. 2018 Jun 1. pii: S0924-8579(18)30157.
    PubMed     Text format     Abstract available


    May 2018
  9. MAFIZ A, Perera LN, He Y, Zhang W, et al
    A Case Study on Soil Antibiotic Resistome in an Urban Community Garden.
    Int J Antimicrob Agents. 2018 May 29. pii: S0924-8579(18)30147.
    PubMed     Text format     Abstract available


  10. MENICHETTI F, Falcone M, Lopalco P, Tascini C, et al
    The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy.
    Int J Antimicrob Agents. 2018 May 23. pii: S0924-8579(18)30141.
    PubMed     Text format     Abstract available


  11. YAHIA HB, Chairat S, Hamdi N, Gharsa H, et al
    Antimicrobial resistance and genetic lineages of faecal enterococci of wild birds: Emergence of vanA and vanB2 harboring Enterococcus faecalis.
    Int J Antimicrob Agents. 2018 May 14. pii: S0924-8579(18)30136.
    PubMed     Text format     Abstract available


    April 2018
  12. RADDAOUI A, Tanfous FB, Chebbi Y, Achour W, et al
    High prevalence of multidrug resistant international clones among macrolide resistant Streptococcus pneumoniae strains in immunocompromised Patients in Tunisia.
    Int J Antimicrob Agents. 2018 Apr 23. pii: S0924-8579(18)30117.
    PubMed     Text format     Abstract available


  13. LEINWEBER H, Alotaibi SMI, Overballe-Petersen S, Hansen F, et al
    Vancomycin resistance in Enterococcus faecium isolated from Danish chicken meat is located on a pVEF4-like plasmid persisting in poultry for 18 years.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30097.
    PubMed     Text format     Abstract available


  14. HAMZAOUI Z, Ocampo-Sosa A, Martinez MF, Landolsi S, et al
    Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC in conferring carbapenem resistance among non-producing carbapenemase-Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30098.
    PubMed     Text format     Abstract available


    March 2018
  15. OH E, Bae J, Kumar A, Choi HJ, et al
    Antioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with bacitracin.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30077.
    PubMed     Text format     Abstract available


  16. SANTOS L, Ramos F
    Antimicrobial resistance in aquaculture: current knowledge and alternatives to tackle the problem.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30081.
    PubMed     Text format     Abstract available


  17. FALAGAS ME, Skalidis T, Vardakas KZ, Voulgaris GL, et al
    Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Int J Antimicrob Agents. 2018 Mar 17. pii: S0924-8579(18)30080.
    PubMed     Text format     Abstract available


  18. PFALLER MA, Huband MD, Mendes RE, Flamm RK, et al
    In vitro activity of meropenem-vaborbactam and characterization of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem-vaborbactam surveillance program.
    Int J Antimicrob Agents. 2018 Mar 3. pii: S0924-8579(18)30064.
    PubMed     Text format     Abstract available


  19. HUANG YT, Liao CH, Chen SY, Hsu HS, et al
    Emergence of multidrug-resistant sequence type 45 strains among borderline oxacillin-resistant mecA-positive Staphylococcus aureus causing bacteraemia in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018 Mar 2. pii: S0924-8579(18)30052.
    PubMed     Text format     Abstract available


    February 2018
  20. STEWART A, Roberts JA, Wallis SC, Allworth AM, et al
    Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat A carbapenem-resistant Pseudomonas aeruginosa lung abscess on an outpatient antimicrobial program.
    Int J Antimicrob Agents. 2018 Feb 19. pii: S0924-8579(18)30046.
    PubMed     Text format    


  21. VUBIL D, Balleste-Delpierre C, Mabunda R, Acacio S, et al
    Antibiotic resistance and molecular characterization of Shigella isolates recovered from children less than 5 years in Manhica, Southern Mozambique.
    Int J Antimicrob Agents. 2018 Feb 12. pii: S0924-8579(18)30043.
    PubMed     Text format     Abstract available


  22. MOHAMMAD H, AbdelKhalek A, Abutaleb NS, Seleem MN, et al
    Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
    Int J Antimicrob Agents. 2018 Feb 9. pii: S0924-8579(18)30041.
    PubMed     Text format     Abstract available


  23. SANTEVECCHI BA, Smith TT, MacVane SH
    Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30019.
    PubMed     Text format     Abstract available


  24. SEO MR, Kim J, Lee Y, Lim DG, et al
    Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30036.
    PubMed     Text format     Abstract available


  25. BARTOLETTI M, Tedeschi S, Pascale R, Raumer L, et al
    Differences in the rate of carbapenem-resistant enterobacteriaceae colonization or clostridium difficile infection following frontline treatment with tigecycline versus meropenem for intra-abdominal infections.
    Int J Antimicrob Agents. 2018 Feb 1. pii: S0924-8579(18)30013.
    PubMed     Text format     Abstract available


    January 2018
  26. LIN YT, Hung WC, Tsai JC, Leong KH, et al
    Wide dissemination of SCCfusC in fusidic acid resistant coagulase-negative staphylococci and implication for its spreading to methicillin-resistant S. aureus in Taiwan.
    Int J Antimicrob Agents. 2018 Jan 30. pii: S0924-8579(18)30031.
    PubMed     Text format     Abstract available


  27. GARCIA-CASTILLO M, Garcia-Fernandez S, Gomez-Gil R, Pitart C, et al
    Activity of ceftazidime-avibactam against carbapenemase-producing enterobacteriaceae from urine samples obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    Int J Antimicrob Agents. 2018 Jan 22. pii: S0924-8579(18)30014.
    PubMed     Text format     Abstract available


  28. ZHANG G, Lin X, Cai J, Zhang R, et al
    Characteristics of clinical and environmental vanM-carrying vancomycin-resistant enterococci isolates from an infected patient.
    Int J Antimicrob Agents. 2018 Jan 12. pii: S0924-8579(18)30006.
    PubMed     Text format     Abstract available


  29. LIEGEON G, Delory T, Picardeau M
    Antibiotic susceptibilities of livestock isolates of leptospira.
    Int J Antimicrob Agents. 2018 Jan 3. pii: S0924-8579(17)30467.
    PubMed     Text format     Abstract available


  30. LU M, Yu C, Cui X, Shi J, et al
    Gentamicin synergises with azoles against drug-resistant Candida albicans.
    Int J Antimicrob Agents. 2018;51:107-114.
    PubMed     Text format     Abstract available


  31. LIU J, Yang L, Chen D, Peters BM, et al
    Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2018;51:145-150.
    PubMed     Text format     Abstract available


  32. WANG R, Liu H, Zhao X, Li J, et al
    IncA/C plasmids conferring high azithromycin resistance in vibrio cholerae.
    Int J Antimicrob Agents. 2018;51:140-144.
    PubMed     Text format     Abstract available


  33. PARVEZ S, Khan AU
    Hospital sewage water: a reservoir for variants of New Delhi metallo-beta-lactamase (NDM)- and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
    Int J Antimicrob Agents. 2018;51:82-88.
    PubMed     Text format     Abstract available


  34. VESTERGAARD M, Nohr-Meldgaard K, Ingmer H
    Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus.
    Int J Antimicrob Agents. 2018;51:132-135.
    PubMed     Text format     Abstract available


  35. LUO HY, Liu MF, Wang MS, Zhao XX, et al
    A novel resistance gene, lnu(H), conferring resistance to lincosamides in Riemerella anatipestifer CH-2.
    Int J Antimicrob Agents. 2018;51:136-139.
    PubMed     Text format     Abstract available


  36. SEIFERT H, Stefanik D, Sutcliffe JA, Higgins PG, et al
    In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;51:62-64.
    PubMed     Text format     Abstract available


  37. VARDAKAS KZ, Voulgaris GL, Samonis G, Falagas ME, et al
    Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:1-9.
    PubMed     Text format     Abstract available


  38. PELLON A, Ramirez-Garcia A, Buldain I, Antoran A, et al
    Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?
    Int J Antimicrob Agents. 2018;51:10-15.
    PubMed     Text format     Abstract available


  39. VIEL A, Henri J, Perrin-Guyomard A, Laroche J, et al
    Lack of experimental evidence to support mcr-1-positive Escherichia coli strain selection during oral administration of colistin at recommended and higher dose given by gavage in weaned piglets.
    Int J Antimicrob Agents. 2018;51:128-131.
    PubMed     Text format     Abstract available


  40. PEETERS LEJ, Croubels S, Rasschaert G, Imberechts H, et al
    Effect of residual doxycycline concentrations on resistance selection and transfer in porcine commensal Escherichia coli.
    Int J Antimicrob Agents. 2018;51:123-127.
    PubMed     Text format     Abstract available


    December 2017
  41. WI YM, Greenwood-Quaintance KE, Brinkman CL, Lee JYH, et al
    Rifampin resistance in staphylococcus epidermidis: molecular characterization and fitness cost of rpoB mutations.
    Int J Antimicrob Agents. 2017 Dec 26. pii: S0924-8579(17)30453.
    PubMed     Text format     Abstract available


  42. VARGAS-ALZATE CA, Higuita-Gutierrez LF, Lopez Lopez L, Cienfuegos Gallet AV, et al
    High excess costs of infections caused by carbapenem-resistant gram-negative bacilli in an endemic region.
    Int J Antimicrob Agents. 2017 Dec 22. pii: S0924-8579(17)30446.
    PubMed     Text format     Abstract available


  43. DIEZ-AGUILAR M, Conejo MC, Morosini MI, Palop NT, et al
    Susceptibility testing and detection of beta-lactam resistance mechanisms in enterobacteriaceae: a multicentre national proficiency study.
    Int J Antimicrob Agents. 2017 Dec 21. pii: S0924-8579(17)30442.
    PubMed     Text format     Abstract available


  44. CHUSRI S, Sakarunchai I, Kositpantawong N, Panthuwong S, et al
    Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017 Dec 11. pii: S0924-8579(17)30436.
    PubMed     Text format     Abstract available


    November 2017
  45. BROWN-JAQUE M, Calero-Caceres W, Espinal P, Rodriguez-Navarro J, et al
    Antibiotic resistance genes in phage particles isolated from human feces and induced from clinical bacterial isolates.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30431.
    PubMed     Text format     Abstract available


  46. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant klebsiella pneumoniae from vietnam.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30429.
    PubMed     Text format     Abstract available


  47. FREITAS AR, Novais C, Duarte B, Pereira AP, et al
    High rates of colonization by ampicillin-resistant enterococci in residents at long-term care facilities in Porto, Portugal.
    Int J Antimicrob Agents. 2017 Nov 23. pii: S0924-8579(17)30418.
    PubMed     Text format     Abstract available


  48. LI W, Liu JH, Zhang XF, Wang J, et al
    Emergence of methicillin-resistant staphylococcus aureus ST398 in pigs in china.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30386.
    PubMed     Text format    


  49. YEON PS, Jung LE, Tark K, Nae YS, et al
    Early administration of appropriate antimicrobial agent to improve the outcome of carbapenem resistant acinetobacter baumannii complex bacteremic pneumonia.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30391.
    PubMed     Text format     Abstract available


    October 2017
  50. IDELEVICH EA, Hoy M, Knaack D, Gorlich D, et al
    Direct determination of carbapenem-resistant enterobacteriaceae and pseudomonas aeruginosa from positive blood cultures using laser scattering technology.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30373.
    PubMed     Text format     Abstract available


    September 2017
  51. CAMPOS J, Mourao J, Silveira L, Saraiva M, et al
    Imported poultry meat as a source of extended-spectrum cephalosporin-resistant CMY-2-producing salmonella heidelberg and s. minnesota in european union, 2014-2015.
    Int J Antimicrob Agents. 2017 Sep 14. pii: S0924-8579(17)30346.
    PubMed     Text format     Abstract available


    August 2017
  52. GIANNELLA M, Trecarichi EM, Giacobbe DR, De FG, et al
    Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection.
    Int J Antimicrob Agents. 2017 Aug 22. pii: S0924-8579(17)30311.
    PubMed     Text format     Abstract available


  53. GUNATHILAKA GU, Tahlan V, Mafiz A, Polur M, et al
    Phage in urban wastewater have the potential to disseminate antibiotic resistance.
    Int J Antimicrob Agents. 2017 Aug 10. pii: S0924-8579(17)30305.
    PubMed     Text format     Abstract available


    July 2017
  54. LOPEZ-CAUSAPE C, de Dios-Caballero J, Cobo M, Escribano A, et al
    Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    Int J Antimicrob Agents. 2017 Jul 20. pii: S0924-8579(17)30284.
    PubMed     Text format     Abstract available


  55. ZHAO L, Liu A, Li R, Zhao S, et al
    Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Int J Antimicrob Agents. 2017 Jul 17. pii: S0924-8579(17)30214.
    PubMed     Text format     Abstract available


  56. BOUZID F, Astier H, Osman DA, Javelle E, et al
    Extended spectrum of antibiotic susceptibility for tuberculosis, djibouti.
    Int J Antimicrob Agents. 2017 Jul 12. pii: S0924-8579(17)30282.
    PubMed     Text format     Abstract available


  57. HOLZKNECHT BJ, Pinholt M, Gumpert H, Hammerum AM, et al
    Genetic characterization confirms sporadic occurrence of vancomycin-resistant Enterococcus faecalis in Copenhagen, Denmark.
    Int J Antimicrob Agents. 2017 Jul 11. pii: S0924-8579(17)30262.
    PubMed     Text format    


  58. BERNABE KJ, Langendorf C, Ford N, Ronat JB, et al
    Antibiotic resistance in West Africa: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Jul 10. pii: S0924-8579(17)30274.
    PubMed     Text format     Abstract available


  59. SUTERA V, Hoarau G, Renesto P, Caspar Y, et al
    In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in francisella tularensis, including in tularaemia patients with treatment failure.
    Int J Antimicrob Agents. 2017 Jul 6. pii: S0924-8579(17)30251.
    PubMed     Text format     Abstract available


  60. WHITE BP, Stover KR, Barber KE, Galloway RC, et al
    Mechanisms of Fosfomycin Resistance in Carbapenem-Resistant Enterobacter spp.
    Int J Antimicrob Agents. 2017 Jul 5. pii: S0924-8579(17)30203.
    PubMed     Text format     Abstract available


  61. LEE MR, Chien JY, Huang YT, Liao CH, et al
    Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Int J Antimicrob Agents. 2017;50:35-40.
    PubMed     Text format     Abstract available


  62. SPARHAM SJ, Kwong JC, Valcanis M, Easton M, et al
    Emergence of multidrug resistance in locally-acquired human infections with Salmonella Typhimurium in Australia owing to a new clade harbouring blaCTX-M-9.
    Int J Antimicrob Agents. 2017;50:101-105.
    PubMed     Text format     Abstract available


    June 2017
  63. CLAEYS KC, Zasowski EJ, Lagnf AM, Levine DP, et al
    Novel Application of Published Risk Factors for Methicillin-Resistant S. aureus in Acute Bacterial Skin and Skin Structure Infections.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30226.
    PubMed     Text format     Abstract available


  64. CHIEN JY, Yu CJ, Hsueh PR
    High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30207.
    PubMed     Text format     Abstract available


  65. SHAH KJ, Cherabuddi K, Shultz J, Borgert S, et al
    Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin resistant enterococcus spp (VRE): a single-center university hospital experience.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30218.
    PubMed     Text format     Abstract available


  66. FERLOV-SCHWENSEN SA, Sydenham TV, Hansen KC, Hoegh SV, et al
    Prevalences of antimicrobial resistance and the cfiA resistance gene in danish bacteroides fragilis group isolates since 1973.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30198.
    PubMed     Text format     Abstract available


  67. KELLY AM, Mathema B, Larson EL
    Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.
    Int J Antimicrob Agents. 2017 Jun 21. pii: S0924-8579(17)30192.
    PubMed     Text format     Abstract available


  68. SORANOGLOU V, Galanopoulos I, Giamarellos-Bourboulis EJ, Papalois A, et al
    Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30175.
    PubMed     Text format     Abstract available


  69. MOROZUMI M, Okada T, Tajima T, Ubukata K, et al
    Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30174.
    PubMed     Text format     Abstract available


  70. LI QJ, Jiao WW, Yin QQ, Li YJ, et al
    Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.
    Int J Antimicrob Agents. 2017;49:757-762.
    PubMed     Text format     Abstract available


  71. DAHDOUH E, Gomez-Gil R, Sanz S, Gonzalez-Zorn B, et al
    A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017;49:727-733.
    PubMed     Text format     Abstract available


  72. WI YM, Choi JY, Lee JY, Kang CI, et al
    Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Int J Antimicrob Agents. 2017;49:767-769.
    PubMed     Text format     Abstract available


  73. LIANG Q, Yin Z, Zhao Y, Liang L, et al
    Sequencing and comparative genomics analysis of the IncHI2 plasmids pT5282-mphA and p112298-catA and the IncHI5 plasmid pYNKP001-dfrA.
    Int J Antimicrob Agents. 2017;49:709-718.
    PubMed     Text format     Abstract available


    May 2017
  74. LOPEZ-DIAZ MC, Rios E, Rodriguez-Avial I, Simaluiza RJ, et al
    In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30172.
    PubMed     Text format     Abstract available


  75. BOURDELLON L, Thilly N, Fougnot S, Pulcini C, et al
    Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by french general practitioners in urinary tract infections: a randomised controlled case-vignette study.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30173.
    PubMed     Text format     Abstract available


  76. JAILLARD M, van Belkum A, Cady KC, Creely D, et al
    Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2017 May 26. pii: S0924-8579(17)30163.
    PubMed     Text format     Abstract available


  77. DUPIEUX C, Kolenda C, Larsen AR, Pichon B, et al
    Variable performance of four commercial chromogenic media for detection of methicillin-resistant Staphylococcus aureus isolates harbouring mecC.
    Int J Antimicrob Agents. 2017 May 23. pii: S0924-8579(17)30166.
    PubMed     Text format     Abstract available


  78. QIN X, Tran BG, Kim MJ, Wang L, et al
    A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Int J Antimicrob Agents. 2017;49:579-588.
    PubMed     Text format     Abstract available


  79. BROUQUI P, Quenard F, Drancourt M
    Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    Int J Antimicrob Agents. 2017;49:554-557.
    PubMed     Text format     Abstract available


  80. CAI X, Yang Z, Dai J, Chen K, et al
    Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Int J Antimicrob Agents. 2017;49:609-616.
    PubMed     Text format     Abstract available


  81. JEANNOT K, Bolard A, Plesiat P
    Resistance to polymyxins in Gram-negative organisms.
    Int J Antimicrob Agents. 2017;49:526-535.
    PubMed     Text format     Abstract available


  82. ZAYYAD H, Eliakim-Raz N, Leibovici L, Paul M, et al
    Revival of old antibiotics: needs, the state of evidence and expectations.
    Int J Antimicrob Agents. 2017;49:536-541.
    PubMed     Text format     Abstract available


  83. KAYE KS, Gales AC, Dubourg G
    Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes.
    Int J Antimicrob Agents. 2017;49:542-548.
    PubMed     Text format     Abstract available


  84. DUBOURG G, Abat C, Raoult D
    Why new antibiotics are not obviously useful now.
    Int J Antimicrob Agents. 2017;49:549-553.
    PubMed     Text format     Abstract available


    April 2017
  85. BI W, Li B, Song J, Hong Y, et al
    Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum beta-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Int J Antimicrob Agents. 2017 Apr 26. pii: S0924-8579(17)30135.
    PubMed     Text format     Abstract available


  86. CHANG YT, Coombs G, Ling T, Balaji V, et al
    Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013.
    Int J Antimicrob Agents. 2017 Apr 20. pii: S0924-8579(17)30121.
    PubMed     Text format     Abstract available


  87. KRAPP F, Grant JL, Sutton SH, Ozer EA, et al
    Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Int J Antimicrob Agents. 2017 Apr 4. pii: S0924-8579(17)30105.
    PubMed     Text format     Abstract available


  88. BI Z, Berglund B, Sun Q, Nilsson M, et al
    Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.
    Int J Antimicrob Agents. 2017;49:493-497.
    PubMed     Text format     Abstract available


  89. MORALES-BARROSO I, Lopez-Cerero L, Molina J, Bellido M, et al
    Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Int J Antimicrob Agents. 2017;49:498-502.
    PubMed     Text format     Abstract available


    March 2017
  90. SYDENHAM TV, Jensen BH, Petersen AM, Krogfelt KA, et al
    Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Int J Antimicrob Agents. 2017 Mar 31. pii: S0924-8579(17)30097.
    PubMed     Text format     Abstract available


  91. FLOKAS ME, Karageorgos SA, Detsis M, Alevizakos M, et al
    Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Mar 20. pii: S0924-8579(17)30086.
    PubMed     Text format     Abstract available


  92. ROCHA IV, das Neves Andrade CA, de Lima Campos T, Rezende AM, et al
    Ciprofloxacin-resistant and extended-spectrum beta-lactamase-producing Escherichia coli ST410 strain carrying the mcr-1 gene associated with bloodstream infection.
    Int J Antimicrob Agents. 2017 Mar 13. pii: S0924-8579(17)30081.
    PubMed     Text format    


  93. PAGANELLI FL, van de Kamer T, Brouwer EC, Leavis HL, et al
    Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium.
    Int J Antimicrob Agents. 2017;49:355-363.
    PubMed     Text format     Abstract available


  94. WEI WJ, Yang HF
    Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Int J Antimicrob Agents. 2017;49:321-326.
    PubMed     Text format     Abstract available


  95. RHOUMA M, Letellier A
    Extended-spectrum beta-lactamases, carbapenemases and the mcr-1 gene: is there a historical link?
    Int J Antimicrob Agents. 2017;49:269-271.
    PubMed     Text format     Abstract available


  96. CHEN CY, Tien FM, Sheng WH, Huang SY, et al
    Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Int J Antimicrob Agents. 2017;49:272-281.
    PubMed     Text format     Abstract available


    February 2017
  97. LAI CC, Chuang YC, Chen CC, Tang HJ, et al
    Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate.
    Int J Antimicrob Agents. 2017 Feb 17. pii: S0924-8579(17)30042.
    PubMed     Text format    


  98. TORPDAHL M, Hasman H, Litrup E, Skov RL, et al
    Detection of mcr-1-encoding plasmid-mediated colistin-resistant Salmonella isolates from human infection in Denmark.
    Int J Antimicrob Agents. 2017;49:261-262.
    PubMed     Text format    


  99. SHARMA R, Patel S, Abboud C, Diep J, et al
    Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Int J Antimicrob Agents. 2017;49:224-232.
    PubMed     Text format     Abstract available


  100. JOHNSON SR, Grad Y, Abrams AJ, Pettus K, et al
    Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance.
    Int J Antimicrob Agents. 2017;49:252-254.
    PubMed     Text format     Abstract available


  101. KOEHLER P, Hamprecht A, Bader O, Bekeredjian-Ding I, et al
    Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Int J Antimicrob Agents. 2017;49:218-223.
    PubMed     Text format     Abstract available


  102. RODRIGUEZ CA, Agudelo M, Zuluaga AF, Vesga O, et al
    In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
    Int J Antimicrob Agents. 2017;49:189-197.
    PubMed     Text format     Abstract available


  103. XIPELL M, Bodro M, Marco F, Losno RA, et al
    Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2017;49:266-268.
    PubMed     Text format    


  104. VARDAKAS KZ, Falagas ME
    Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017;49:233-238.
    PubMed     Text format     Abstract available


    January 2017
  105. PULCINI C, Tebano G, Mutters NT, Tacconelli E, et al
    Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.
    Int J Antimicrob Agents. 2017 Jan 10. pii: S0924-8579(17)30007.
    PubMed     Text format     Abstract available


  106. ORTIZ DE LA TABLA V, Ortega A, Bunuel F, Perez-Vazquez M, et al
    Detection of the high-risk clone ST131 of Escherichia coli carrying the colistin resistance gene mcr-1 and causing acute peritonitis.
    Int J Antimicrob Agents. 2017;49:115-116.
    PubMed     Text format    


  107. FERNANDO DM, Chong P, Singh M, Spicer V, et al
    Multi-omics approach to study global changes in a triclosan-resistant mutant strain of Acinetobacter baumannii ATCC 17978.
    Int J Antimicrob Agents. 2017;49:74-80.
    PubMed     Text format     Abstract available


  108. UNGER F, Eisenberg T, Prenger-Berninghoff E, Leidner U, et al
    Imported reptiles as a risk factor for the global distribution of Escherichia coli harbouring the colistin resistance gene mcr-1.
    Int J Antimicrob Agents. 2017;49:122-123.
    PubMed     Text format    


  109. OPOTA O, Diene SM, Bertelli C, Prod'hom G, et al
    Genome of the carbapenemase-producing clinical isolate Elizabethkingia miricola EM_CHUV and comparative genomics with Elizabethkingia meningoseptica and Elizabethkingia anophelis: evidence for intrinsic multidrug resistance trait of emerging pathogens
    Int J Antimicrob Agents. 2017;49:93-97.
    PubMed     Text format     Abstract available


  110. CHOI HJ, Kil MC, Choi JY, Kim SJ, et al
    Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Int J Antimicrob Agents. 2017;49:102-106.
    PubMed     Text format     Abstract available


  111. BROWN K, Uwiera RR, Kalmokoff ML, Brooks SP, et al
    Antimicrobial growth promoter use in livestock: a requirement to understand their modes of action to develop effective alternatives.
    Int J Antimicrob Agents. 2017;49:12-24.
    PubMed     Text format     Abstract available


    December 2016
  112. DOMINGUEZ-HERRERA J, Lopez-Rojas R, Smani Y, Labrador-Herrera G, et al
    Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Int J Antimicrob Agents. 2016;48:661-665.
    PubMed     Text format     Abstract available


  113. OLAITAN AO, Li J
    Emergence of polymyxin resistance in Gram-negative bacteria.
    Int J Antimicrob Agents. 2016;48:581-582.
    PubMed     Text format    


  114. GIAMARELLOU H
    Epidemiology of infections caused by polymyxin-resistant pathogens.
    Int J Antimicrob Agents. 2016;48:614-621.
    PubMed     Text format     Abstract available


  115. GAO Q, Wu S, Huang H, Ni Y, et al
    Toxin profiles, PCR ribotypes and resistance patterns of Clostridium difficile: a multicentre study in China, 2012-2013.
    Int J Antimicrob Agents. 2016;48:736-739.
    PubMed     Text format     Abstract available


  116. CAI J, Wang Y, Schwarz S, Zhang G, et al
    High detection rate of the oxazolidinone resistance gene optrA in Enterococcus faecalis isolated from a Chinese anorectal surgery ward.
    Int J Antimicrob Agents. 2016;48:757-759.
    PubMed     Text format    


  117. YANAT B, Machuca J, Yahia RD, Touati A, et al
    First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria.
    Int J Antimicrob Agents. 2016;48:760-761.
    PubMed     Text format    


  118. BARON S, Hadjadj L, Rolain JM, Olaitan AO, et al
    Molecular mechanisms of polymyxin resistance: knowns and unknowns.
    Int J Antimicrob Agents. 2016;48:583-591.
    PubMed     Text format     Abstract available


    November 2016
  119. MISCHNIK A, Baumert P, Hamprecht A, Rohde A, et al
    Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Int J Antimicrob Agents. 2016 Nov 28. pii: S0924-8579(16)30349.
    PubMed     Text format     Abstract available


  120. GOMEZ-ZORRILLA S, Calatayud L, Juan C, Cabot G, et al
    Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model.
    Int J Antimicrob Agents. 2016 Nov 28. pii: S0924-8579(16)30352.
    PubMed     Text format     Abstract available


  121. HWANG D, Kim SM, Kim HJ
    Modelling of tetracycline resistance gene transfer by commensal Escherichia coli food isolates that survived in gastric fluid conditions.
    Int J Antimicrob Agents. 2016 Nov 22. pii: S0924-8579(16)30345.
    PubMed     Text format     Abstract available


  122. GUIGNARD B, Majcherczyk PA, Monachon C, Vouillamoz J, et al
    Muropeptide signature of inhibitors of protein synthesis correlates with beta-lactam synergism against methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Nov 16. pii: S0924-8579(16)30335.
    PubMed     Text format     Abstract available


  123. PERDIGAO J, Maltez F, Machado D, Silva H, et al
    Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscess.
    Int J Antimicrob Agents. 2016;48:569-570.
    PubMed     Text format    


  124. LANG PM, Jacinto RC, Dal Pizzol TS, Ferreira MB, et al
    Resistance profiles to antimicrobial agents in bacteria isolated from acute endodontic infections: systematic review and meta-analysis.
    Int J Antimicrob Agents. 2016;48:467-474.
    PubMed     Text format     Abstract available


  125. MCNEIL HC, Lean SS, Lim V, Clarke SC, et al
    The state of ESKAPE in Malaysia.
    Int J Antimicrob Agents. 2016;48:578-579.
    PubMed     Text format    


  126. ISNARD C, Fines-Guyon M, Toublet FX, Guerin F, et al
    In vivo emergence of rifampicin resistance by rpoB mutation in Listeria monocytogenes during therapy of prosthetic joint infection.
    Int J Antimicrob Agents. 2016;48:572-574.
    PubMed     Text format    


  127. LIN YT, Huang YW, Huang HH, Yang TC, et al
    In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
    Int J Antimicrob Agents. 2016;48:485-491.
    PubMed     Text format     Abstract available


  128. TSIOUTIS C, Kritsotakis EI, Karageorgos SA, Stratakou S, et al
    Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Int J Antimicrob Agents. 2016;48:492-497.
    PubMed     Text format     Abstract available


    October 2016
  129. OVIANO M, Sparbier K, Barba MJ, Kostrzewa M, et al
    Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS).
    Int J Antimicrob Agents. 2016 Oct 20. pii: S0924-8579(16)30285.
    PubMed     Text format     Abstract available


  130. SINEL C, Jaussaud C, Auzou M, Giard JC, et al
    Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates.
    Int J Antimicrob Agents. 2016;48:449-52.
    PubMed     Text format     Abstract available


  131. BAI L, Hurley D, Li J, Meng Q, et al
    Characterisation of multidrug-resistant Shiga toxin-producing Escherichia coli cultured from pigs in China: co-occurrence of extended-spectrum beta-lactamase- and mcr-1-encoding genes on plasmids.
    Int J Antimicrob Agents. 2016;48:445-8.
    PubMed     Text format     Abstract available


  132. SIMO TCHUINTE PL, Stalder T, Venditti S, Ngandjio A, et al
    Characterisation of class 3 integrons with oxacillinase gene cassettes in hospital sewage and sludge samples from France and Luxembourg.
    Int J Antimicrob Agents. 2016;48:431-4.
    PubMed     Text format     Abstract available


  133. MOHSIN M, Raza S, Roschanski N, Schaufler K, et al
    First description of plasmid-mediated colistin-resistant extended-spectrum beta-lactamase-producing Escherichia coli in a wild migratory bird from Asia.
    Int J Antimicrob Agents. 2016;48:463-4.
    PubMed     Text format    


    September 2016
  134. PIRES J, Bernasconi OJ, Kasraian S, Hilty M, et al
    Intestinal colonisation with extended-spectrum cephalosporin-resistant Escherichia coli in Swiss pets: molecular features, risk factors and transmission with owners.
    Int J Antimicrob Agents. 2016 Sep 20. pii: S0924-8579(16)30238.
    PubMed     Text format    


  135. LENHARD JR, Gall JS, Bulitta JB, Thamlikitkul V, et al
    Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016 Sep 20. pii: S0924-8579(16)30239.
    PubMed     Text format     Abstract available


  136. COREY GR, Arhin FF, Wikler MA, Sahm DF, et al
    Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Sep 13. pii: S0924-8579(16)30232.
    PubMed     Text format     Abstract available


  137. BABOUEE FLURY B, Ellington MJ, Hopkins KL, Turton JF, et al
    The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae.
    Int J Antimicrob Agents. 2016 Sep 12. pii: S0924-8579(16)30234.
    PubMed     Text format     Abstract available


  138. LIU X, Zhao M, Chen Y, Bian X, et al
    Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
    Int J Antimicrob Agents. 2016 Sep 8. pii: S0924-8579(16)30231.
    PubMed     Text format     Abstract available


  139. HAMZE M, Osman M, Achkar M, Mallat H, et al
    Alarming increase in prevalence of Neisseria gonorrhoeae infections associated with a high level of antibiotic resistance in Tripoli, Lebanon.
    Int J Antimicrob Agents. 2016 Sep 7. pii: S0924-8579(16)30226.
    PubMed     Text format    


  140. PAPP JR, Lawrence K, Sharpe S, Mueller J, et al
    In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione.
    Int J Antimicrob Agents. 2016;48:328-30.
    PubMed     Text format     Abstract available


  141. WANG R, Li J, Kan B
    Sequences of a co-existing SXT element, a chromosomal integron (CI) and an IncA/C plasmid and their roles in multidrug resistance in a Vibrio cholerae O1 El Tor strain.
    Int J Antimicrob Agents. 2016;48:305-9.
    PubMed     Text format     Abstract available


  142. KUTI JL, Ghazi IM, Quintiliani R Jr, Shore E, et al
    Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration.
    Int J Antimicrob Agents. 2016;48:342-3.
    PubMed     Text format    


  143. RAO GG, Ly NS, Diep J, Forrest A, et al
    Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;48:331-6.
    PubMed     Text format     Abstract available


  144. HUANG SF, Chang JS, Sheu CC, Liu YT, et al
    An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit.
    Int J Antimicrob Agents. 2016;48:286-91.
    PubMed     Text format     Abstract available


    August 2016
  145. GAYMARD A, Pichon M, Degaud M, Tasse J, et al
    Methicillin-resistant Staphylococcus aureus in the environment of public transport: data from the metropolitan network in Lyon, France.
    Int J Antimicrob Agents. 2016 Aug 17. pii: S0924-8579(16)30208.
    PubMed     Text format     Abstract available


  146. MARINO A, Blanco AR, Ginestra G, Nostro A, et al
    Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2016 Aug 11. pii: S0924-8579(16)30201.
    PubMed     Text format     Abstract available


  147. CHOI IS, Lee YJ, Wi YM, Kwan BS, et al
    Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Int J Antimicrob Agents. 2016;48:175-80.
    PubMed     Text format     Abstract available


  148. SOLHEIM M, Bohlin J, Ulstad CR, Schau Slettemeas J, et al
    Plasmid-mediated colistin-resistant Escherichia coli detected from 2014 in Norway.
    Int J Antimicrob Agents. 2016;48:227-8.
    PubMed     Text format    


  149. COURT R, Gordon M, Cohen K, Stewart A, et al
    Random lopinavir concentrations predict resistance on lopinavir-based antiretroviral therapy.
    Int J Antimicrob Agents. 2016;48:158-62.
    PubMed     Text format     Abstract available


  150. SADER HS, Castanheira M, Farrell DJ, Flamm RK, et al
    Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).
    Int J Antimicrob Agents. 2016;48:144-50.
    PubMed     Text format     Abstract available


  151. RHOUMA M, Beaudry F, Letellier A
    Resistance to colistin: what is the fate for this antibiotic in pig production?
    Int J Antimicrob Agents. 2016;48:119-26.
    PubMed     Text format     Abstract available


    July 2016
  152. QUEENAN K, Hasler B, Rushton J
    A One Health approach to antimicrobial resistance surveillance: is there a business case for it?
    Int J Antimicrob Agents. 2016 Jul 25. pii: S0924-8579(16)30183.
    PubMed     Text format     Abstract available


  153. ZHAO M, Liang L, Ji L, Chen D, et al
    Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
    Int J Antimicrob Agents. 2016 Jul 19. pii: S0924-8579(16)30166.
    PubMed     Text format     Abstract available


  154. DIMITRIADIS P, Protonotariou E, Varlamis S, Poulou A, et al
    Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016 Jul 7. pii: S0924-8579(16)30155.
    PubMed     Text format     Abstract available


  155. POURNARAS S, Koumaki V, Spanakis N, Gennimata V, et al
    Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance.
    Int J Antimicrob Agents. 2016;48:11-8.
    PubMed     Text format     Abstract available


  156. PAVEZ M, Vieira C, de Araujo MR, Cerda A, et al
    Molecular mechanisms of membrane impermeability in clinical isolates of Enterobacteriaceae exposed to imipenem selective pressure.
    Int J Antimicrob Agents. 2016;48:78-85.
    PubMed     Text format     Abstract available


  157. KUO HY, Hsu PJ, Chen JY, Liao PC, et al
    Clonal spread of blaOXA-72-carrying Acinetobacter baumannii sequence type 512 in Taiwan.
    Int J Antimicrob Agents. 2016;48:111-3.
    PubMed     Text format     Abstract available


  158. HIJAZI K, Mukhopadhya I, Abbott F, Milne K, et al
    Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections.
    Int J Antimicrob Agents. 2016;48:86-90.
    PubMed     Text format     Abstract available


  159. MATHLOUTHI N, El Salabi AA, Ben Jomaa-Jemili M, Bakour S, et al
    Early detection of metallo-beta-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
    Int J Antimicrob Agents. 2016;48:46-50.
    PubMed     Text format     Abstract available


    June 2016
  160. SUBIRATS J, Sanchez-Melsio A, Borrego CM, Balcazar JL, et al
    Metagenomic analysis reveals that bacteriophages are reservoirs of antibiotic resistance genes.
    Int J Antimicrob Agents. 2016 Jun 3. pii: S0924-8579(16)30120.
    PubMed     Text format     Abstract available


  161. JAHANBAKHSH S, Smith MG, Kohan-Ghadr HR, Letellier A, et al
    Dynamics of extended-spectrum cephalosporin resistance in pathogenic Escherichia coli isolated from diseased pigs in Quebec, Canada.
    Int J Antimicrob Agents. 2016 Jun 1. pii: S0924-8579(16)30118.
    PubMed     Text format     Abstract available


  162. DAVIDO B, Bouchand F, Calin R, Makhloufi S, et al
    High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospital.
    Int J Antimicrob Agents. 2016;47:490-4.
    PubMed     Text format     Abstract available


  163. YU CY, Ang GY, Chin PS, Ngeow YF, et al
    Emergence of mcr-1-mediated colistin resistance in Escherichia coli in Malaysia.
    Int J Antimicrob Agents. 2016;47:504-5.
    PubMed     Text format    


  164. LOPEZ-ROJAS R, Garcia-Quintanilla M, Labrador-Herrera G, Pachon J, et al
    Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;47:473-7.
    PubMed     Text format     Abstract available


  165. FREITAS AR, Novais C, Read A, Alves V, et al
    Co-infection with three linezolid-resistant Enterococcus faecium ST117 strain variants: what are we missing in diagnosis?
    Int J Antimicrob Agents. 2016;47:500-1.
    PubMed     Text format    


    May 2016
  166. FALGENHAUER L, Imirzalioglu C, Ghosh H, Gwozdzinski K, et al
    Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany.
    Int J Antimicrob Agents. 2016 May 12. pii: S0924-8579(16)30086.
    PubMed     Text format     Abstract available


  167. BANERJEE S, Sundeep S, Sarma J, Oswald T, et al
    Assume nothing! Staphylococcus aureus resistance to daptomycin may occur in patients not previously exposed to daptomycin or glycopeptides.
    Int J Antimicrob Agents. 2016;47:418-9.
    PubMed     Text format    


  168. CAVALIE L, Mantion B, Fayet O, Prere MF, et al
    blaNDM-1-positive Citrobacter sedlakii: emergence after horizontal gene transfer from Klebsiella pneumoniae in the human intestinal tract.
    Int J Antimicrob Agents. 2016;47:411-3.
    PubMed     Text format    


  169. KHALIFA HO, Ahmed AM, Oreiby AF, Eid AM, et al
    Characterisation of the plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli isolated from animals in Egypt.
    Int J Antimicrob Agents. 2016;47:413-4.
    PubMed     Text format    


  170. TENG JC, Lingaratnam SM, Trubiano JA, Thursky KA, et al
    Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes.
    Int J Antimicrob Agents. 2016;47:391-6.
    PubMed     Text format     Abstract available


  171. GOMEZ-ZORRILLA S, Juan C, Cabot G, Camoez M, et al
    Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.
    Int J Antimicrob Agents. 2016;47:368-74.
    PubMed     Text format     Abstract available


  172. MENEGUCCI TC, Albiero J, Migliorini LB, Alves JL, et al
    Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.
    Int J Antimicrob Agents. 2016;47:380-5.
    PubMed     Text format     Abstract available


    April 2016
  173. MAHAMAT A, Bertrand X, Moreau B, Hommel D, et al
    Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Int J Antimicrob Agents. 2016 Apr 25. pii: S0924-8579(16)30052.
    PubMed     Text format     Abstract available


  174. ABBOUD CS, Monteiro J, Stryjewski ME, Zandonadi EC, et al
    Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Int J Antimicrob Agents. 2016 Apr 6. pii: S0924-8579(16)30046.
    PubMed     Text format     Abstract available


  175. KANAFANI ZA, Kmeid J, Nawar T, Assaf SM, et al
    Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon.
    Int J Antimicrob Agents. 2016 Apr 2. pii: S0924-8579(16)30042.
    PubMed     Text format    


  176. RAOULT D
    Alice's living croquet theory.
    Int J Antimicrob Agents. 2016;47:249.
    PubMed     Text format    


  177. LOB SH, Hoban DJ, Sahm DF, Badal RE, et al
    Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;47:317-23.
    PubMed     Text format     Abstract available


  178. LI X, Mu X, Yang Y, Hua X, et al
    Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
    Int J Antimicrob Agents. 2016;47:324-7.
    PubMed     Text format     Abstract available


    March 2016
  179. SUN Q, Ba Z, Wu G, Wang W, et al
    Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates.
    Int J Antimicrob Agents. 2016 Mar 24. pii: S0924-8579(16)30023.
    PubMed     Text format     Abstract available


  180. BROWNE C, Muszbek N, Chapman R, Marsh K, et al
    Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
    Int J Antimicrob Agents. 2016 Mar 19. pii: S0924-8579(16)30021.
    PubMed     Text format     Abstract available


  181. HASSING RJ, Goessens WH, Zeneyedpour L, Sultan S, et al
    Detection of amino acid substitutions in the GyrA protein of fluoroquinolone-resistant typhoidal Salmonella isolates using high-resolution mass spectrometry.
    Int J Antimicrob Agents. 2016 Mar 15. pii: S0924-8579(16)30019.
    PubMed     Text format     Abstract available


  182. CHEN H, Xiong Z, Liu K, Li S, et al
    Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
    Int J Antimicrob Agents. 2016 Mar 12. pii: S0924-8579(16)30016.
    PubMed     Text format     Abstract available


  183. KIM JS, Kim MJ, Kim SJ, Shin E, et al
    First description of CTX-M-3 extended-spectrum beta-lactamase in an outbreak strain of Shiga toxin-producing Escherichia coli O103:H2.
    Int J Antimicrob Agents. 2016;47:244-5.
    PubMed     Text format    


  184. GHOSH H, Doijad S, Bunk B, Falgenhauer L, et al
    Detection of translocatable units in a blaCTX-M-15 extended-spectrum beta-lactamase-producing ST131 Escherichia coli isolate using a hybrid sequencing approach.
    Int J Antimicrob Agents. 2016;47:245-7.
    PubMed     Text format    


  185. OUYANG W, Xue H, Chen Y, Gao W, et al
    Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
    Int J Antimicrob Agents. 2016;47:210-6.
    PubMed     Text format     Abstract available


  186. THANGAMANI S, Mohammad H, Abushahba MF, Sobreira TJ, et al
    Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    Int J Antimicrob Agents. 2016;47:195-201.
    PubMed     Text format     Abstract available


    February 2016
  187. SYUE LS, Chen YH, Ko WC, Hsueh PR, et al
    New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
    Int J Antimicrob Agents. 2016 Feb 21. pii: S0924-8579(16)00045.
    PubMed     Text format     Abstract available


  188. JEAN SS, Coombs G, Ling T, Balaji V, et al
    Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Int J Antimicrob Agents. 2016 Feb 17. pii: S0924-8579(16)00042.
    PubMed     Text format     Abstract available


  189. NI W, Han Y, Zhao J, Wei C, et al
    Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2016;47:107-16.
    PubMed     Text format     Abstract available


    January 2016
  190. OLAITAN AO, Morand S, Rolain JM
    Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Int J Antimicrob Agents. 2016;47:1-3.
    PubMed     Text format     Abstract available


  191. RIOU M, Avrain L, Carbonnelle S, El Garch F, et al
    Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.
    Int J Antimicrob Agents. 2016;47:77-83.
    PubMed     Text format     Abstract available


  192. ALONSO N, Miro E, Pascual V, Rivera A, et al
    Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
    Int J Antimicrob Agents. 2016;47:62-8.
    PubMed     Text format     Abstract available


  193. VESTERGAARD M, Paulander W, Marvig RL, Clasen J, et al
    Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2016;47:48-55.
    PubMed     Text format     Abstract available


    December 2015
  194. KLEIN S, Nurjadi D, Eigenbrod T, Bode KA, et al
    Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
    Int J Antimicrob Agents. 2015 Dec 21. pii: S0924-8579(15)00405.
    PubMed     Text format     Abstract available


  195. THAMLIKITKUL V, Tiengrim S, Seenama C
    Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
    Int J Antimicrob Agents. 2015 Dec 11. pii: S0924-8579(15)00397.
    PubMed     Text format    


  196. SCHMITZ RP, Rissner F, Brunkhorst FM
    The Thuringian registry for bloodstream infections, antibiotic resistance and the practice of blood culture sampling-AlertsNet.
    Int J Antimicrob Agents. 2015;46 Suppl 1:S5-9.
    PubMed     Text format     Abstract available


    November 2015
  197. STREEKSTRA H, Keuter A, Wilms L
    Reaction to Dalhoff and Levy: 'Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern'.
    Int J Antimicrob Agents. 2015;46:595-6.
    PubMed     Text format    


  198. DALHOFF A
    Response to the reaction to Dalhoff and Levy: 'Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern'.
    Int J Antimicrob Agents. 2015;46:596-7.
    PubMed     Text format    


    September 2015
  199. OLAITAN AO, Rolain JM
    Interruption of mgrB in the mediation of colistin resistance in Klebsiella oxytoca.
    Int J Antimicrob Agents. 2015;46:354-5.
    PubMed     Text format    


    July 2015
  200. JAYOL A, Poirel L, Villegas MV, Nordmann P, et al
    Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca.
    Int J Antimicrob Agents. 2015;46:108-10.
    PubMed     Text format     Abstract available


  201. SADER HS, Castanheira M, Flamm RK, Mendes RE, et al
    Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Int J Antimicrob Agents. 2015;46:53-9.
    PubMed     Text format     Abstract available


  202. DE KNEGT GJ, Bakker-Woudenberg IA, van Soolingen D, Aarnoutse R, et al
    SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    Int J Antimicrob Agents. 2015;46:66-72.
    PubMed     Text format     Abstract available


  203. ANK N, Sydenham TV, Iversen LH, Justesen US, et al
    Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing.
    Int J Antimicrob Agents. 2015;46:117-20.
    PubMed     Text format     Abstract available


  204. ZHOU L, Yang L, Zeng X, Danzheng J, et al
    Transcriptional and proteomic analyses of two-component response regulators in multidrug-resistant Mycobacterium tuberculosis.
    Int J Antimicrob Agents. 2015;46:73-81.
    PubMed     Text format     Abstract available


  205. VIVAS M, Force E, Tubau F, El Haj C, et al
    Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
    Int J Antimicrob Agents. 2015;46:28-32.
    PubMed     Text format     Abstract available


    June 2015
  206. DALHOFF AA, Levy SB
    Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern.
    Int J Antimicrob Agents. 2015;45:564-7.
    PubMed     Text format     Abstract available


  207. POTRON A, Poirel L, Nordmann P
    Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
    Int J Antimicrob Agents. 2015;45:568-85.
    PubMed     Text format     Abstract available


  208. ZENTENO-CUEVAS R, Xochihua-Gonzalez O, Cuevas-Cordoba B, Victoria-Cota NL, et al
    Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
    Int J Antimicrob Agents. 2015;45:671-3.
    PubMed     Text format    


  209. MOURAO J, Novais C, Machado J, Peixe L, et al
    Metal tolerance in emerging clinically relevant multidrug-resistant Salmonella enterica serotype 4,[5],12:i:- clones circulating in Europe.
    Int J Antimicrob Agents. 2015;45:610-6.
    PubMed     Text format     Abstract available


  210. LO HJ, Tseng KY, Kao YY, Tsao MY, et al
    Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Int J Antimicrob Agents. 2015;45:617-21.
    PubMed     Text format     Abstract available


  211. VOURLI S, Frantzeskaki F, Meletiadis J, Stournara L, et al
    Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
    Int J Antimicrob Agents. 2015;45:670-1.
    PubMed     Text format    


  212. OLAITAN AO, Dia NM, Gautret P, Benkouiten S, et al
    Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj.
    Int J Antimicrob Agents. 2015;45:600-4.
    PubMed     Text format     Abstract available


  213. WANG X, Chen H, Zhang Y, Wang Q, et al
    Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Int J Antimicrob Agents. 2015;45:635-40.
    PubMed     Text format     Abstract available


    May 2015
  214. FALAGAS ME, Vardakas KZ, Kapaskelis A, Triarides NA, et al
    Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
    Int J Antimicrob Agents. 2015;45:455-60.
    PubMed     Text format     Abstract available


  215. ZHANG Z, Pang Y, Wang Y, Cohen C, et al
    Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Int J Antimicrob Agents. 2015;45:491-5.
    PubMed     Text format     Abstract available


  216. SAIPROM N, Amornchai P, Wuthiekanun V, Day NP, et al
    Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Int J Antimicrob Agents. 2015;45:557-9.
    PubMed     Text format    


  217. DOUKA E, Perivolioti E, Kraniotaki E, Fountoulis K, et al
    Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit.
    Int J Antimicrob Agents. 2015;45:533-6.
    PubMed     Text format     Abstract available


  218. SOLOMENNYI A, Goncharov A, Zueva L
    Extensively drug-resistant Acinetobacter baumannii belonging to the international clonal lineage I in a Russian burn intensive care unit.
    Int J Antimicrob Agents. 2015;45:525-8.
    PubMed     Text format     Abstract available


  219. SCHINDLER BD, Jacinto PL, Buensalido JA, Seo SM, et al
    Clonal relatedness is a predictor of spontaneous multidrug efflux pump gene overexpression in Staphylococcus aureus.
    Int J Antimicrob Agents. 2015;45:464-70.
    PubMed     Text format     Abstract available


    April 2015
  220. GONZALO X, Casali N, Broda A, Pardieu C, et al
    Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
    Int J Antimicrob Agents. 2015;45:406-12.
    PubMed     Text format     Abstract available


  221. GOPAL P, Dick T
    The new tuberculosis drug Perchlozone(R) shows cross-resistance with thiacetazone.
    Int J Antimicrob Agents. 2015;45:430-3.
    PubMed     Text format     Abstract available


  222. AL-MARZOOQ F, Ngeow YF, Tay ST
    Emergence of Klebsiella pneumoniae producing dual carbapenemases (NDM-1 and OXA-232) and 16S rRNA methylase (armA) isolated from a Malaysian patient returning from India.
    Int J Antimicrob Agents. 2015;45:445-6.
    PubMed     Text format    


  223. MACHAIRAS N, Pistiki A, Droggiti DI, Georgitsi M, et al
    Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.
    Int J Antimicrob Agents. 2015;45:376-84.
    PubMed     Text format     Abstract available


  224. LAFEUILLE E, Laouira S, Sougakoff W, Soulier-Escrihuela O, et al
    Detection of OXA-48-like carbapenemase genes by the Xpert(R) Carba-R test: room for improvement.
    Int J Antimicrob Agents. 2015;45:441-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: